Connection

Anne-Catrin Uhlemann to Enterobacteriaceae

Back to Details
This is a "connection" page, showing publications Anne-Catrin Uhlemann has written about Enterobacteriaceae.
Anne-Catrin Uhlemann
Connection Strength
2.246
Enterobacteriaceae
  1. Clonal Background, Resistance Gene Profile, and Porin Gene Mutations Modulate In Vitro Susceptibility to Imipenem-Relebactam in Diverse Enterobacteriaceae. Antimicrob Agents Chemother. 2018 08; 62(8).
    View in: PubMed
    Score: 0.548
  2. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One. 2017; 12(10):e0186195.
    View in: PubMed
    Score: 0.518
  3. Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC ß-Lactamases?" Antimicrob Agents Chemother. 2017 09; 61(9).
    View in: PubMed
    Score: 0.514
  4. Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC ß-Lactamase-Producing Enterobacteriaceae. Antimicrob Agents Chemother. 2017 06; 61(6).
    View in: PubMed
    Score: 0.505
  5. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States. Antimicrob Agents Chemother. 2017 04; 61(4).
    View in: PubMed
    Score: 0.125
  6. Multicenter Evaluation of Colistin Broth Disk Elution and Colistin Agar Test: a Report from the Clinical and Laboratory Standards Institute. J Clin Microbiol. 2019 11; 57(11).
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.